The Diagnostic Journey: ERG, OCT, and Genetic Testing

Navigating the medical tests for a rare condition like Achromatopsia can feel like learning a new language. To provide a definitive diagnosis, doctors look for a specific “triad” of evidence: how the eye reacts to light, what the eye looks like structurally, and the specific genetic code causing the condition ^[1][2].

1. ERG (Electroretinography)

Think of the ERG as an “EKG for the eye.” It measures the electrical response of the retina’s light-sensing cells ^[3].

• What it looks for: The test is divided into “light-adapted” (photopic) and “dark-adapted” (scotopic) phases.
• What the report may say: In a child with Achromatopsia, the report will typically show “non-recordable” or “severely diminished” cone responses in the light-adapted phase ^[3]. However, the rod responses in the dark-adapted phase usually remain relatively healthy or “preserved” ^[3]. This is the “smoking gun” that tells doctors the problem is specifically with the cones, not the rods.

2. OCT (Optical Coherence Tomography)

The OCT is a non-invasive imaging test that takes a high-resolution cross-section of the retina. It’s like a “live biopsy” that lets doctors see the individual layers of the eye ^[4].

• What it looks for: Doctors examine the fovea (the center of the retina) to see if the cone cells are physically present, even if they aren’t working.
• What the report may say: You may see terms like “Ellipsoid Zone (EZ) disruption” or “Foveal Hypoplasia” ^[5][6]. This means the central part of the retina didn’t develop fully or shows some wear and tear. Seeing a “residual cone mosaic” on an OCT is often a positive sign for future gene therapy, as it means there are still cells available to “rescue” ^[5][7].

3. Molecular Genetic Testing

While ERGs and OCTs show how the eye is failing, Genetic Testing tells you why ^[8].

• What it looks for: It searches for mutations in one of the six known Achromatopsia genes (most commonly CNGB3 or CNGA3) ^[9].
• Why it is critical: Confirmation of the specific gene is now a mandatory requirement for almost all clinical trials for gene therapy ^[1][10].

What if the test is inconclusive?
Sometimes, a child’s clinical signs point entirely to Achromatopsia, but the genetic test comes back negative or inconclusive. Do not panic. Researchers are still discovering new genes related to vision. An inconclusive test does not invalidate your child’s experience, nor does it change the effectiveness of their standard low-vision care, filters, and educational accommodations ^[11].

The Diagnosis “Completeness Checklist”

To ensure your child has a “complete” diagnosis that prepares them for future medical advancements, your medical file should eventually contain:

• [ ] Full-Field ERG Report: Confirming absent cone function ^[3].
• [ ] Macular OCT Scans: Assessing the health of the central retinal layers ^[2].
• [ ] Genetic Testing Report: Identifying the specific pathogenic variants (mutations) ^[8].
• [ ] Acuity & Color Testing: A baseline of their current visual performance (even if they cannot see any color) ^[9].

If your child has only had one or two of these, talk to your ophthalmologist about completing the set. Having all three results is the best way to “future-proof” your child’s care as new treatments emerge ^[10][12].